Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
22-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
22-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #56106
advertisement
Fu J
20
Showing records 1 to 20 |
Display all abstracts from
Fu J
99098
Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
He C
Oxidative medicine and cellular longevity
2022; 2022: 8063651
99132
New loci for refractive errors and ocular biometric parameters in young Chinese Han adults
Sun Y
Science China Life Sciences
2022; 65: 2050-2061
99098
Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Zhang G
Oxidative medicine and cellular longevity
2022; 2022: 8063651
99132
New loci for refractive errors and ocular biometric parameters in young Chinese Han adults
Jin ZB; Wei S
Science China Life Sciences
2022; 65: 2050-2061
99098
Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Fu J
Oxidative medicine and cellular longevity
2022; 2022: 8063651
99132
New loci for refractive errors and ocular biometric parameters in young Chinese Han adults
Jia H
Science China Life Sciences
2022; 65: 2050-2061
99098
Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Zhang R
Oxidative medicine and cellular longevity
2022; 2022: 8063651
99132
New loci for refractive errors and ocular biometric parameters in young Chinese Han adults
Cao K
Science China Life Sciences
2022; 65: 2050-2061
99098
Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Li A; Liu D
Oxidative medicine and cellular longevity
2022; 2022: 8063651
99132
New loci for refractive errors and ocular biometric parameters in young Chinese Han adults
Hu J
Science China Life Sciences
2022; 65: 2050-2061
99098
Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Li B
Oxidative medicine and cellular longevity
2022; 2022: 8063651
99132
New loci for refractive errors and ocular biometric parameters in young Chinese Han adults
Lin C
Science China Life Sciences
2022; 65: 2050-2061
99098
Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Chen Y
Oxidative medicine and cellular longevity
2022; 2022: 8063651
99132
New loci for refractive errors and ocular biometric parameters in young Chinese Han adults
An W; Guo J
Science China Life Sciences
2022; 65: 2050-2061
99098
Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Deng B
Oxidative medicine and cellular longevity
2022; 2022: 8063651
99132
New loci for refractive errors and ocular biometric parameters in young Chinese Han adults
Li H; Fu J
Science China Life Sciences
2022; 65: 2050-2061
99098
Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Shuai P
Oxidative medicine and cellular longevity
2022; 2022: 8063651
99132
New loci for refractive errors and ocular biometric parameters in young Chinese Han adults
Li SM
Science China Life Sciences
2022; 65: 2050-2061
99098
Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study
Lu F
Oxidative medicine and cellular longevity
2022; 2022: 8063651
99132
New loci for refractive errors and ocular biometric parameters in young Chinese Han adults
Wang N;
Science China Life Sciences
2022; 65: 2050-2061
Issue
22-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept